• Ibrexafungerp Activity Against Candida in Acidic Vaginal pH

  2026-06-01

  This study demonstrates that ibrexafungerp (MK 3118), a novel triterpenoid antifungal, retains potent activity against both fluconazole-susceptible and -resistant Candida isolates at acidic vaginal pH. The findings support its translational relevance for vulvovaginal candidiasis, where conventional azoles often lose efficacy.

• HCMV-Induced AKT Inactivation via UL38-Mediated IRS1 Destabi

  2026-06-01

  This study reveals that human cytomegalovirus (HCMV) inactivates AKT not by direct inhibition, but through UL38-driven destabilization of insulin receptor substrate proteins. These findings clarify a key negative feedback mechanism in virus-host signaling and highlight experimental considerations for the study of protein phosphorylation pathways in infected cells.

• Fluorescein Tyramide: Transforming Signal Amplification in N

  2026-05-31

  Explore how Fluorescein Tyramide, a powerful fluorescent labeling dye, advances signal amplification in immunohistochemistry and in situ hybridization. This article uniquely connects the reagent’s utility to cutting-edge neurodevelopmental studies on oxytocin signaling and early life adversity.

• IP3R/Ca2+/STAT3 Pathway Drives Apoptosis in Nanoplastic–Cadm

  2026-05-30

  This study elucidates how simultaneous exposure to polystyrene nanoplastics and cadmium induces intestinal cell apoptosis via the IP3R/Ca2+/STAT3 signaling pathway. The findings provide critical mechanistic insight into environmental co-contaminant toxicity and highlight the value of calcium chelation for dissecting cell signaling in toxicology research.

• HucMSCs Mitigate High Glucose-Impaired Vasculogenesis via MA

  2026-05-29

  This article reviews the recent iScience study demonstrating that human umbilical cord-derived mesenchymal stem cells (hucMSCs) alleviate high glucose-induced defects in vasculogenesis through downregulation of the MAPK signaling pathway. The findings highlight the need to address early vasculogenic impairment in diabetic vascular complications and provide mechanistic insight relevant for stem cell-based therapeutic strategies.

• Prednisolone in Applied Glucocorticoid Signaling Research

  2026-05-29

  Prednisolone’s high purity and robust receptor activation make it an essential tool for dissecting glucocorticoid signaling and inflammation modulation in modern research workflows. This article details optimized protocols, advanced applications, and troubleshooting strategies, connecting recent insights from ERAD-based protein degradation to practical immunology and cellular assay design.

• Magneto-Piezoelectric Scaffolds Target Icam1+ Macrophages in

  2026-05-28

  This study introduces magneto-piezoelectric nanoparticle-enhanced scaffolds that target Icam1+ macrophages to disrupt biofilms and restore bone regeneration in infectious bone defects. By activating oxidative phosphorylation via the JAK2-STAT3 pathway, these advanced scaffolds improve healing outcomes and offer a paradigm shift in the management of infection-impaired bone repair.

• p53/PUMA-Mediated Lethality via WRN Inhibition in MSI Colore

  2026-05-28

  This study uncovers how synthetic lethality in mismatch repair-deficient colorectal cancer is mediated by p53 and PUMA activation following Werner helicase inhibition. The work clarifies the molecular mechanism linking WRN loss to apoptosis in microsatellite instable cancers, informing targeted therapeutic strategies.

• Ferroelectric-Liquid Metal Hybrids for Biomimetic Visual Pro

  2026-05-27

  This study introduces a ferroelectric-liquid metal hybrid artificial photoreceptor capable of mimicking human visual adaptation across visible and infrared light. The material demonstrates robust photoelectric conversion, biocompatibility, and potential for next-generation retinal prostheses, representing a significant advance in bioelectronic vision restoration.

• Ibrexafungerp: Translational Breakthrough in Acidic-Resistan

  2026-05-27

  Explore how Ibrexafungerp (MK 3118) uniquely addresses the challenge of antifungal efficacy in acidic environments, advancing in vitro and in vivo research. This article reveals critical assay insights and practical applications that set Ibrexafungerp apart in the fight against resistant Candida.

• a-MSH, amide (A1025): Reliable Solutions for Pigmentation Re

  2026-05-26

  This article explores real-world laboratory challenges in pigmentation regulation and anti-inflammatory peptide research, demonstrating how 'a-MSH, amide' (SKU A1025) from APExBIO provides reproducible, data-backed solutions. Scenario-driven Q&A blocks guide researchers through protocol optimization, data interpretation, and product selection, grounded in peer-reviewed evidence and practical expertise.

• Ibrexafungerp (SKU C8697): Data-Driven Solutions for Antifun

  2026-05-26

  This article guides biomedical researchers through practical, scenario-based challenges in antifungal assay design and interpretation, demonstrating how Ibrexafungerp (SKU C8697) from APExBIO delivers reproducible, reliable results. By leveraging recent evidence and validated protocols, the discussion positions Ibrexafungerp as a robust choice for in vitro and in vivo candidiasis research, especially when resistance or acidic pH complicate workflows.

• Methotrexate as a Folate Antagonist: Protocols & Pitfalls

  2026-05-25

  Methotrexate’s dual role as a folate antagonist and DHFR inhibitor enables precise modeling of apoptosis and immunosuppression in translational research. This article provides actionable workflow enhancements, troubleshooting insights, and a bridge to emerging methylation research—empowering reproducible, high-impact studies.

• WM-8014: Redefining KAT6A Inhibition for Translational Epige

  2026-05-25

  This thought-leadership article explores the pivotal role of WM-8014 in advancing translational epigenetics and cancer biology research. By integrating mechanistic insights, experimental validation, and strategic guidance, we outline how WM-8014—a selective, reversible KAT6A inhibitor—enables precise oncogene-induced senescence induction without cytotoxicity. The discussion bridges evidence from advanced CRISPR-based screens, places WM-8014 in the competitive landscape, and articulates its translational relevance, providing actionable protocols and a forward-looking perspective for researchers seeking to map epigenetic dependencies in oncogenesis.

• ALT Cancer Cells and ATR Inhibition: No General Hypersensiti

  2026-05-24

  This study rigorously tested whether cancer cells using alternative lengthening of telomeres (ALT) are broadly hypersensitive to ATR inhibition. Contrary to previous reports, the authors found that ALT status alone does not predict cell viability loss upon ATR inhibitor treatment, highlighting the need for more specific therapeutic markers.

16989 records 1/1133 page Next 12345 下5页 Last page